Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I3TD
|
||||
| Former ID |
DIB016025
|
||||
| Drug Name |
CRL-37212
|
||||
| Synonyms |
Anaplastic lymphoma kinase inhibitors (cancer); CRL-37212; CRL-43425; CRL-82007; ALK inihibitors (cancer), ChemBridge Research; Anaplastic lymphoma kinase inhibitors (cancer), ChemBridge Research
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543509] | ||
| Company |
ChemBridge Research Laboratories LLC
|
||||
| Canonical SMILES |
c1c(ccc2c1OCO2)c1c[nH]c(=O)c(c1)C(=O)Nc1ccc(cc1)CCN1CCN<br />(CC1)C
|
||||
| Target and Pathway | |||||
| Target(s) | ALK tyrosine kinase receptor | Target Info | Inhibitor | [543509] | |
| KEGG Pathway | Non-small cell lung cancer | ||||
| WikiPathways | Differentiation Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.